ESC-HFA 2024: Late-Breaking Science Video Collection
Published: 14 May 2024
-
Views:
1374
-
Likes:
7
-
Views:
1374
-
Likes:
7
-
15m 26sPart 1 | Session 1 HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie Harriette Van Spall, Mark Petrie
-
10m 15sPart 1 | Session 2 Late-Breaker Discussion: The TITRATE-HF Study Harriette Van Spall, Jasper J Brugts
-
12m 4sPart 1 | Session 3 Late-Breaker Discussion: Insights from the STEP-HFpEF Harriette Van Spall, Mikhail Kosiborod
-
8m 37sPart 1 | Session 4 Late-Breaker Discussion: Findings from PACT-HF Harriette Van Spall, Tauben Averbuch
-
2m 45sPart 2 | Session 1 Remote Patient Monitoring for Patients With Heart Failure: TELESAT Nicolas Girerd
-
5m 3sPart 2 | Session 2 Cordella PA Sensor System in NYHA Class III HF Patients: PROACTIVE-HF Michael Kiernan
-
7m 19sPart 2 | Session 3 Aspirin Avoidance after Implantation of a Fully Magnetically Levitated LVAD: ARIES HM3 Finn Gustafsson
-
5m 24sPart 2 | Session 4 Timing of Cardio-Kidney Protection with SGLT2i Muthiah Vaduganathan
-
2m 54sPart 2 | Session 5 Treatment Benefit Consistency of Remote Hemodynamic Monitoring in CHF: MONITOR-HF Subgroup Analysis Jasper J Brugts
-
4m 46sPart 2 | Session 6 Inter-Atrial Shunt Treatment to Reduce Lung Congestion in Patients with Advanced Heart Failure: RELIEVE-HF Stefan Anker
-
4m 40sPart 2 | Session 7 FINE-HEART: Design & Baseline Characteristics Muthiah Vaduganathan
Overview
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Association’s annual congress, Heart Failure 2024.
Dive deep into novel data with in-depth and critical discussions led by Late-breaker host Dr Harriette Van Spall and her expert guests.
For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators.
More from this programme
Part 1
Late-breaker Discussions with Dr Van Spall
Part 2
Expert Interviews
About the episode
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.
RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had been treated with guideline-directed drug and device therapies were enrolled in the trial, and randomized 1:1 to recieve either the interatrial shunt, or were part of the control arm. In this interview, Dr Zile outlines the differencial effects of inter-atrial shunt treatment on cardiac structure and function in patients with reduced vs preserved ejection fraction.
Findings showed that in HFrEF, interatrial shunt treatment was tolerated without increased right ventricular preload or afterload. In HFpEF, left and right heart were non-compliant at baseline, and remained non-compliant after interatrial shunt treatment. These findings suggest a mechanistic basis for the differences in clinical outcomes seen between both arms.
Interview Questions:
- What is the reasoning behind this study?
- Could you tell us more about the V-Wave shunt system?
- What was the patient population and study design?
- What are the key findings in regard to treament effects in patients with HFpEF and HFrEF?
- What are your take-home messages?
- Where are the knowledge gaps, and what further study is needed?
Recorded onsite at HFA 2024, Lisbon.
Support: This is an independent interview conducted by Radcliffe Cardiology.
Editor: Jordan Rance
Video Specialists: Tom Green, Oliver Miles
Interviewer: Jonathan McKenna
Faculty Biographies
Michael R Zile
Charles Ezra Daniel Professor of Medicine
Dr. Zile is currently the Charles Ezra Daniel Professor of Medicine and Distinguished University Professor at the Medical University of South Carolina. He is a member of the Cardiology Division at the Ralph H. Johnson Department of Veteran's Affairs Health Care System in Charleston. He is also the Director of the SmartState SC Center of Economic Excellence: Molecular Proteomics in Cardiovascular Disease, Prevention and Treatment. He is an Adjunct Professor of Bioengineering at Clemson University. He is the 2019 William S. Middleton Awardee for Outstanding Achievement in Biomedical Research and the 2020 South Carolina Governor’s Awardee for Excellence in Scientific Research. Dr. Zile's research career has focused on basic, translational and clinical research examining the mechanisms underlying the development and progression of heart failure; and determining how these mechanisms can be used to develop effective diagnostic, prognostic and treatment methods for…
Comments